EHC

SEC source: 0001127602-18-023498 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,521

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023492 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,637

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023489 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,777

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023486 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,637

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023480 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,367

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023477 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,344

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023476 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,607

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023475 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,197

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-017454 · form4.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,269

F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.72 to $62.74, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

SEC source: 0001127602-18-017149 · form4.xml · nonDerivative · entry 1

Levy Cheryl B. · CIK 0001513212 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,522

SEC source: 0001127602-18-016523 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,595

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016522 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,297

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016521 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,284

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016519 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,540

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016520 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,554

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016518 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,554

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016517 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,130

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016516 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,107

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016515 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,370

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016514 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,971

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-016151 · form4.xml · derivative · entry 3

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,792

Underlying: Encompass Health Common Stock · 3,897 shares

Expires 2027-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing February 24, 2018.

SEC source: 0001127602-18-016151 · form4.xml · nonDerivative · entry 2

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,067

F1 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $62.490 to $62.515, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

SEC source: 0001127602-18-016151 · form4.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-015935 · form4.xml · derivative · entry 4

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Encompass Health Common Stock · 33,100 shares

Expires 2019-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-015935 · form4.xml · nonDerivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,963

F2 · price: This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.575, inclusive.

SEC source: 0001127602-18-015935 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,538

F1 · price: This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2) below.

SEC source: 0001127602-18-015935 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-014895 · form4.xml · nonDerivative · entry 2

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,585

F2 · shares: This number represents the purchase of (a) 431 shares of common stock of Encompass Health Corporation (the "Company") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the "Plan") and (b) 195 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2017 to defer fixed percentages of their directors fees for 2018. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 16, 2018, the Company paid a dividend on common stock of $0.25 per share.

F3 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $57.98 to $57.99, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

SEC source: 0001127602-18-014886 · form4.xml · nonDerivative · entry 2

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,209

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 16, 2018, the Company paid a dividend on common stock of $0.25 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-18-014885 · form4.xml · nonDerivative · entry 2

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,898

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 16, 2018, the Company paid a dividend on common stock of $0.25 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-18-014895 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,959

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014894 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,984

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014893 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,721

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014892 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,744

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014890 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,168

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014889 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,154

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014888 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,168

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014886 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,147

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-014885 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,890

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-010002 · form4.xml · derivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,547

Underlying: Healthsouth Common Stock · 51,547 shares

Expires 2028-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2019.

SEC source: 0001127602-18-009999 · form4.xml · derivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,151

Underlying: Healthsouth Common Stock · 12,151 shares

Expires 2028-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2019.

SEC source: 0001127602-18-009998 · form4.xml · derivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,494

Underlying: Healthsouth Common Stock · 10,494 shares

Expires 2028-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2019.

SEC source: 0001127602-18-009996 · form4.xml · derivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,619

Underlying: Healthsouth Common Stock · 20,619 shares

Expires 2028-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2019.

SEC source: 0001127602-18-008482 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,963

F2 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-008482 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,604

F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 18, 2016.

SEC source: 0001127602-18-008481 · form4.xml · nonDerivative · entry 2

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,465

F2 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-008481 · form4.xml · nonDerivative · entry 1

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,327

F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 18, 2016.

SEC source: 0001127602-18-008480 · form4.xml · nonDerivative · entry 2

Levy Cheryl B. · CIK 0001513212 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,504

F2 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-008480 · form4.xml · nonDerivative · entry 1

Levy Cheryl B. · CIK 0001513212 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,212

F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 18, 2016.

SEC source: 0001127602-18-008479 · form4.xml · nonDerivative · entry 2

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,067

F2 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.